Use of prostaglandin E1, E2 or analogs to prevent renal failure induced by medical tests that utilize contrast media agents

Use of prostaglandin E1, E2 or analogs to prevent renal failure induced by medical tests that utilize contrast media agents

A method of preventing renal failure or dysfunction caused by medical tests which utilize contrast media by administering, preferably by intravenous infusion or injection, a prostaglandin selected from PGE1, PGE2, PGI2 or an analog or pharmaceutically acceptable salt thereof and preferably in a form...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ANTONUCCI, TAMMY K, STRATTON, HENRY T, SCHOLLMAYER, ERWIN
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A method of preventing renal failure or dysfunction caused by medical tests which utilize contrast media by administering, preferably by intravenous infusion or injection, a prostaglandin selected from PGE1, PGE2, PGI2 or an analog or pharmaceutically acceptable salt thereof and preferably in a form of a complex with alpha -cyclodextrin, to a patient at risk, for example, a diabetic.